NY S 6074
in committeeEstablishes the Sickle cell disease education and mapping program
New York · 2025-2026 Regular Session · upper
Quick answers
Did NY S 6074 pass?
Not yet. NY S 6074 is in committee as of 2026-01-07 and has not come to a final vote. Latest recorded action (2026-01-07): REFERRED TO HEALTH
What is NY S 6074 about?
Establishes the sickle cell disease education and mapping program to promote the screening and detection of sickle cell disease, educate the public regarding sickle cell disease, provide counseling and referral services and map locations of occurrence of sickle cell disease.
Who sponsors NY S 6074?
Kevin S. Parker is the primary sponsor of NY S 6074.
Description
Establishes the sickle cell disease education and mapping program to promote the screening and detection of sickle cell disease, educate the public regarding sickle cell disease, provide counseling and referral services and map locations of occurrence of sickle cell disease.
- Introduced
- —
- Latest action
- 2026-01-07 — REFERRED TO HEALTH
- Bill type
- bill
- Last updated
- —
Sponsors
- Kevin S. Parkerprimary
Committees
Not provided by source.
Action timeline
2025-03-05
REFERRED TO HEALTH
referral-committee
2026-01-07
REFERRED TO HEALTH
referral-committee
Versions
- S6074Compare
Documents
Votes
Not provided by source.
Related bills
- Prior session: S 8923not in this corpus
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 6074. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.